|
IKZF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.140300E-03 |
| Normal-vs-Stage3 |
1.39290000000791E-06 |
| Normal-vs-Stage4 |
1.579460E-04 |
| Stage1-vs-Stage2 |
6.464200E-02 |
| Stage1-vs-Stage3 |
5.643300E-03 |
| Stage1-vs-Stage4 |
4.592400E-02 |
| Stage2-vs-Stage3 |
9.528000E-01 |
| Stage2-vs-Stage4 |
8.492400E-01 |
| Stage3-vs-Stage4 |
8.576000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65234492754962E-12 |
| Normal-vs-AfricanAmerican |
1.878940E-03 |
| Normal-vs-Asian |
1.99370000508736E-08 |
| Caucasian-vs-AfricanAmerican |
8.287200E-01 |
| Caucasian-vs-Asian |
3.363200E-01 |
| AfricanAmerican-vs-Asian |
7.143600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.05740013703837E-10 |
| Normal-vs-Female |
1.6269208202857E-12 |
| Male-vs-Female |
7.898000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.66133814775094E-16 |
| Normal-vs-Age(41-60Yrs) |
6.99470481535513E-11 |
| Normal-vs-Age(61-80Yrs) |
9.61369999999961E-05 |
| Normal-vs-Age(81-100Yrs) |
7.766800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.634500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.438650E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.499900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.522790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.545900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.306600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.14650000002403E-06 |
| Classical-VS-Follicular |
3.618200E-03 |
| Classical-VS-Other |
4.063200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.358010E-01 |
| Tall-VS-Other |
2.419600E-01 |
| Tall-VS-Normal |
6.660100E-02 |
| Follicular-VS-Other |
8.823800E-01 |
| Follicular-VS-Normal |
3.955100E-04 |
| Other-VS-Normal |
7.056000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.00439689687937E-11 |
| Normal-vs-N1 |
4.60019999981576E-07 |
| N0-vs-N1 |
8.716400E-01 |
|
|
